|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
49,450,000 |
Market
Cap: |
1.26(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$26.1 - $47.5 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 623 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
119,323 |
119,323 |
201,796 |
291,198 |
Total Sell Value |
$3,656,226 |
$3,656,226 |
$6,836,738 |
$12,122,941 |
Total People Sold |
1 |
1 |
15 |
17 |
Total Sell Transactions |
3 |
3 |
36 |
59 |
End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Stack David M |
President and CEO |
|
2013-03-28 |
4 |
OE |
$1.61 |
$24,150 |
D/D |
15,000 |
17,573 |
|
- |
|
Scibetta James S |
Chief Financial Officer |
|
2013-03-28 |
4 |
AS |
$28.49 |
$284,900 |
D/D |
(10,000) |
5,000 |
|
- |
|
Scibetta James S |
Chief Financial Officer |
|
2013-03-28 |
4 |
OE |
$1.61 |
$16,100 |
D/D |
10,000 |
15,000 |
|
- |
|
Hbm Bioventures Cayman Ltd |
10% Owner |
|
2013-03-25 |
4 |
AS |
$28.28 |
$4,680,738 |
D/D |
(165,541) |
2,233,993 |
|
- |
|
Wicki Andreas |
Director |
|
2013-03-25 |
4 |
AS |
$28.28 |
$4,680,738 |
I/I |
(165,541) |
2,233,993 |
|
- |
|
Hbm Bioventures Cayman Ltd |
10% Owner |
|
2013-03-22 |
4 |
AS |
$27.52 |
$3,135,595 |
D/D |
(113,928) |
2,399,534 |
|
- |
|
Wicki Andreas |
Director |
|
2013-03-22 |
4 |
AS |
$27.52 |
$3,135,595 |
I/I |
(113,928) |
2,399,534 |
|
- |
|
Hbm Bioventures Cayman Ltd |
10% Owner |
|
2013-03-21 |
4 |
AS |
$27.50 |
$314,353 |
D/D |
(11,431) |
2,513,462 |
|
- |
|
Wicki Andreas |
Director |
|
2013-03-21 |
4 |
AS |
$27.50 |
$314,353 |
I/I |
(11,431) |
2,513,462 |
|
- |
|
Wicki Andreas |
Director |
|
2013-03-19 |
4 |
AS |
$27.86 |
$253,501 |
I/I |
(9,100) |
2,524,893 |
|
- |
|
Hbm Bioventures Cayman Ltd |
10% Owner |
|
2013-03-19 |
4 |
AS |
$27.86 |
$253,501 |
D/D |
(9,100) |
2,524,893 |
|
- |
|
Middleton Fred A |
Director |
|
2013-03-19 |
4 |
AS |
$26.95 |
$2,306,831 |
D/D |
(84,589) |
416,083 |
|
- |
|
Stack David M |
President and CEO |
|
2013-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
573 |
2,573 |
|
- |
|
Wicki Andreas |
Director |
|
2013-03-18 |
4 |
AS |
$28.19 |
$11,277,480 |
I/I |
(400,000) |
2,533,993 |
|
- |
|
Hbm Bioventures Cayman Ltd |
10% Owner |
|
2013-03-18 |
4 |
AS |
$28.19 |
$11,277,480 |
D/D |
(400,000) |
2,533,993 |
|
- |
|
Middleton Fred A |
Director |
|
2013-03-18 |
4 |
AS |
$28.19 |
$4,745,234 |
D/D |
(165,411) |
0 |
|
- |
|
Evnin Luke |
Director |
|
2013-03-18 |
4 |
S |
$28.44 |
$14,220,000 |
I/I |
(500,000) |
2,290,479 |
|
- |
|
Middleton Fred A |
Director |
|
2013-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,133 |
67,966 |
|
- |
|
Middleton Fred A |
Director |
|
2013-03-15 |
4 |
AS |
$0.00 |
$0 |
D/D |
(200,000) |
0 |
|
- |
|
Sanderling Venture Partners Vi Co Investment Fund |
10% Owner |
|
2013-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
200,000 |
|
- |
|
Sanderling Venture Partners Vi Co Investment Fund |
10% Owner |
|
2013-03-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,000,000) |
361,762 |
|
- |
|
Riker Lauren Bullaro |
Executive Director, Accounting |
|
2013-03-14 |
4 |
S |
$30.00 |
$300,000 |
D/D |
(10,000) |
2,000 |
|
- |
|
Riker Lauren Bullaro |
Executive Director, Accounting |
|
2013-03-14 |
4 |
OE |
$10.34 |
$103,400 |
D/D |
10,000 |
12,000 |
|
- |
|
Pratt John |
General Manager, San Diego |
|
2013-03-12 |
4 |
S |
$28.46 |
$266,813 |
D/D |
(9,375) |
0 |
|
- |
|
Pratt John |
General Manager, San Diego |
|
2013-03-12 |
4 |
OE |
$8.73 |
$81,844 |
D/D |
9,375 |
9,375 |
|
- |
|
272 Records found
|
|
Page 8 of 11 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|